FDA Approves First Ablation Catheters for the Treatment of Atrial Fibrillation
The U.S. Food and Drug Administration today approved the first ablation catheters for the treatment of atrial fibrillation (uncoordinated contractions of the upper heart chambers), one of the most common types of arrhythmias, or abnormal heart rhythms, affecting more than two million Americans.